Thomasian Harry Jr. sold $183K of PGEN
Thomasian Harry Jr. (Chief Financial Officer) sold 41,884 shares of PRECIGEN, INC. (PGEN) at $4.36 ($0.18M total) on 2026-05-28.
How this was made
The 30-second read
Why it matters
This provides a datapoint on insider behavior (open-market sale) but does not introduce new company fundamentals like trial results, guidance, financing, or contracts.
Market read
Traders may monitor for follow-through selling pressure, but the filing alone is unlikely to drive a durable repricing.
What to watch
Insider sales often occur for tax/financial planning; without context on total compensation, prior sales, or remaining holdings, signal strength is weak.
Background
The article is an SEC EDGAR Form 4 insider transaction disclosure by Precigen’s CFO.
Ticker impact
SEC Form 4 shows CFO Harry Jr. sold 41,884 shares of Precigen at $4.36/share, disclosing direct insider selling activity.
Low near-term impact; any move is likely sentiment-driven and limited unless accompanied by other news.
The filing is an ownership-change disclosure with no new operating/financial information; also explicitly notes no 10b5-1 plan, which can raise attention but still lacks a direct causal catalyst.
Market effects
Limited read-across to biotech/clinical-stage sentiment; insider selling is company-specific and typically not sector-wide.
None indicated; US-listed microcap/small-cap style flow effects only.
None indicated.
Counterpoint
The sale could be routine liquidity/portfolio rebalancing; absence of a 10b5-1 plan does not necessarily imply negative fundamentals.
Key entities
- issuerPRECIGEN, INC.
Company whose CFO reported an open-market sale of shares via SEC Form 4.
- insiderThomasian Harry Jr.
Precigen CFO who sold 41,884 shares at $4.36/share.
